Project Grant R01HG013679
Award Date
9/19/24
Completion Date
6/30/28
Dollars Obligated
$744K
Federal Agency
National Human Genome Research Institute
Federal Grant Program
93.172
Assistance Type
Project Grant
Place of Performance
Cambridge, MA 02138, USA
Similar Awards
The National Human Genome Research Institute (NHGRI), under the Human Genome Research Federal Grant Program (CFDA 93.172), awarded a $404,117 Project Grant to Panluminate Inc., a woman-owned small business, to develop CHROMEX30, a novel variant of their proprietary Pan-Expansion Microscopy (PAN-EXM) technology. This project aims to enable nanoscale (sub-10 nm) imaging of genetic organization and disease phenotypes using a standard confocal microscope, which addresses a key challenge in the field...
The National Human Genome Research Institute (NHGRI) awarded a $400,000 Project Grant (CFDA 93.172 - Human Genome Research) to the University of Washington to develop new single-cell multi-omic technologies for studying the relationship between three-dimensional genome organization and gene expression. Specifically, the grant will fund the development of CARE-Seq, a novel method to jointly measure whole-genome chromatin interactions and gene expression in the same single cells from complex...
The National Human Genome Research Institute (NHGRI), under the Human Genome Research Federal Grant Program (CFDA 93.172), awarded a $384,418 Project Grant to Xgenomes Corp. on September 25, 2024 to develop a revolutionary DNA sequencing platform. The project aims to create a super-resolution single-molecule sequencing technology that can read short sequence "words" rather than individual nucleotides, enabling one or more orders of magnitude improvements in accuracy and cost over...
This $653,880 Project Grant awarded by the National Human Genome Research Institute (NHGRI) under the Human Genome Research program (CFDA 93.172) supports the development of a high-content, image-based CRISPR screening platform to discover regulators of three-dimensional (3D) genome architecture across multiple length scales. The goal is to advance screening technology to enable large-scale, multi-omic analysis of the spatial organization of the genome, nucleome, and transcriptome. Key...
This Project Grant award, ID R21HG014016, was provided by the National Human Genome Research Institute (NHGRI) under the Human Genome Research program (CFDA 93.172). The award, totaling $222,933, supports the development of "Self-EvolvR", a new self-refreshing DNA barcode technology for high-resolution lineage tracing across various biological systems. The key objectives are to construct the Self-EvolvR system, validate its performance in bacterial and eukaryotic models, and enhance...
The National Human Genome Research Institute (NHGRI), under the 93.172 Human Genome Research federal grant program, awarded a $3,377,867 Project Grant to Survey Genomics, Inc. on September 19, 2024. The grant supports the development and commercialization of the CytopeDrop platform, an innovative approach for spatially-resolved single-cell multiomics analysis. CytopeDrop enables researchers to simultaneously obtain mRNA abundances, protein abundances, and cell locations, providing crucial...
This Project Grant award of $1,375,594.00 from the National Human Genome Research Institute (CFDA 93.172 - Human Genome Research) supports the development of a novel platform called Helicase-Assisted Continuous Evolution (HACE) for performing multiplexed locus-specific hypermutation within the mammalian genome. The HACE system utilizes a nick-directed helicase fused to a deaminase domain to introduce continuous mutations in large genomic targets, directed by a Cas9 nickase and locus-specific...
This $1,737,000 Project Grant awarded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) supports the development of innovative single-cell genomics technologies for joint analysis of regulatory dynamics and transcriptional states. Key objectives include: Developing multiomics tools to measure rates of epigenomic changes (DNA methylation, demethylation, oxidative damage, DNA repair) and relate these to...
The National Human Genome Research Institute (NHGRI), under the Human Genome Research Federal Grant Program (CFDA 93.172), awarded Evizia Inc. a $1,234,692 Project Grant (Award ID R44HG014079) to develop a novel biomolecule desktop imaging system called PRECYSE. This system, based on high-speed atomic force microscopy (HSAFM), can rapidly analyze DNA samples for next-generation sequencing (NGS) quality control. The system can size DNA fragments from 100 base pairs to over 250 kilobases in...
This $470,575 Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the CFDA 93.286 Discovery and Applied Research for Technological Innovations to Improve Human Health program, supports research at Harvard Medical School to develop programmable human artificial chromosomes (HACs) for cell-based therapeutics, diagnostics, and screening. The key objectives are to: 1) program the HAC to induce expression of therapeutic proteins in response to...